医保药品支付标准分类管理研究
发布时间：2018-08-28 08:50
【摘要】：介绍了临床价值、市场属性、质量属性等医保药品支付标准的常见分类依据,比较了重庆、福建、天津、德国、我国台湾地区的医保药品支付标准分类方式,在此基础上建议我国实行医保药品支付标准分类管理,同时构建信息平台。
[Abstract]:This paper introduces the common classification basis of medical insurance drug payment standard, such as clinical value, market attribute and quality attribute, and compares the classification methods of medical insurance drug payment standard in Chongqing, Fujian, Tianjin, Germany and Taiwan. On the basis of this, it is suggested that our country should implement the standard classification management of medical insurance drug payment, and construct the information platform at the same time.
【作者单位】： 中国药科大学国家药物政策与医药产业经济研究中心;
【基金】：2015年度国家社科基金重大项目(第二批)“我国创新药物政策环境研究”(15ZDB167)
【分类号】：R95
本文编号：2208897
[Abstract]:This paper introduces the common classification basis of medical insurance drug payment standard, such as clinical value, market attribute and quality attribute, and compares the classification methods of medical insurance drug payment standard in Chongqing, Fujian, Tianjin, Germany and Taiwan. On the basis of this, it is suggested that our country should implement the standard classification management of medical insurance drug payment, and construct the information platform at the same time.
【作者单位】： 中国药科大学国家药物政策与医药产业经济研究中心;
【基金】：2015年度国家社科基金重大项目(第二批)“我国创新药物政策环境研究”(15ZDB167)
【分类号】：R95
【相似文献】
相关硕士学位论文 前1条
1 刘桂圆;药品价格改革形势下医保药品支付标准的研究[D];东南大学;2017年
，本文编号：2208897
本文链接：https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/2208897.html
最近更新
教材专著
